The ubiquitin-proteasome system: Potential therapeutic targets for alzheimer’s disease and spinal cord injury

Frontiers in Molecular Neuroscience

Volumn 9, Issue JAN, 2016, Pages

  Gong, Bing ^a,b   Radulovic, Miroslav ^a,b,c   Figueiredo Pereira, Maria E ^d   Cardozo, Christopher ^a,b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Center of Excellence for the Medical Consequences of Spinal Cord Injury   (United States)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Alzheimer s disease; Beta amyloid clearance; Neuroregeneration; Spinal cord injuries; Ubiquitin proteasome system

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; F BOX PROTEIN; UBIQUITIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; COGNITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; GENE MUTATION; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; UBIQUITIN PROTEASOME SYSTEM;

EID: 84957881321     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00004     Document Type: Review

References (172)

1. Adams, J. (2003). The proteasome: structure, function and role in the cell. Cancer Treat. Rev. 29, 3-9. doi: 10.1016/s0305-7372(03)00081-1
2. Ahlgren, S., Li, G. L., and Olsson, Y. (1996). Accumulation of p-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsymaterial. ActaNeuropathol. 92, 49-55. doi: 10.1007/s004010050488
3. Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., et al. (2008). Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 65, 1509-1517. doi: 10.1001/archneur.65.11.1509
4. Alves-Rodrigues, A., Gregori, L., and Figueiredo-Pereira, M. E. (1998). Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21, 516-520. doi: 10.1016/s0166-2236(98)01276-4
5. Araki, T., and Milbrandt, J. (2003). ZNRF proteins constitute a family of presynaptic E3 ubiquitin ligases. J. Neurosci. 23, 9385-9394.
6. Atkin, G., Hunt, J., Minakawa, E., Sharkey, L., Tipper, N., Tennant, W., et al. (2014). F-boxonlyprotein 2 (Fbxo2) regulates amyloid precursor protein levels and processing. J. Biol. Chem. 289, 7038-7048. doi: 10.1074/jbc.m113.515056
7. Atkin, G., and Paulson, H. (2014). Ubiquitin pathways in neurodegenerative disease. Front. Mol. Neurosci. 7:63. doi: 10.3389/fnmol.2014.00063
8. Ayyadevara, S., Balasubramaniam, M., Gao, Y., Yu, L. R., Alla, R., and Shmookler Reis, R. (2015). Proteins in aggregates functionally impact multipleneurodegenerative disease models byformingproteasome-blockingcomplexes. AgingCell 14, 35-48. doi: 10.1111/acel.12296
9. Bedford, L., Paine, S., Rezvani, N., Mee, M., Lowe, J., and Mayer, R. J. (2009). The UPS and autophagy in chronic neurodegenerative disease: six of one and half a dozen of the other-or not? Autophagy 5, 224-227. doi: 10.4161/auto.5.2.7389
10. Bence, N. F., Sampat, R. M., and Kopito, R. R. (2001). Impairment ofthe ubiquitin- proteasome system by protein aggregation. Science 292, 1552-1555. doi: 10.1126/science.292.5521.1552
11. Bishop, P., Rubin, P., Thomson, A. R., Rocca, D., and Henley, J. M. (2014). The ubiquitin C-terminal hydrolase L1 (Uch-L1) C-terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons. J. Biol. Chem. 289, 36140-36149. doi: 10.1074/jbc.m114.557124
12. Blumbergs, P. C., Scott, G., Manavis, J., Wainwright, H., Simpson, D. A., and McLean, A. J. (1995). Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J. Neurotrauma 12, 565-572. doi: 10.1089/neu.1995.12.565
13. Calingasan, N. Y., Chen, J., Kiaei, M., and Beal, M. F. (2005). p-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol. Dis. 19, 340-347. doi: 10.1016/j.nbd.2005.01.012
14. Carlucci, A., Lignitto, L., and Feliciello, A. (2008). Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome. TrendsCellBiol. 18, 604-613. doi: 10.1016/j.tcb.2008.09.006
15. Cartier, A. E., Djakovic, S. N., Salehi, A., Wilson, S. M., Masliah, E., and Patrick, G. N. (2009). Regulation of synaptic structure byubiquitin C-terminal hydrolase L1. J. Neurosci. 29, 7857-7868. doi: 10.1523/JNEUROSCI.1817-09.2009
16. Chain, D. G., Schwartz, J. H., and Hegde, A. N. (1999). Ubiquitin-mediated proteolysis in learning and memory. Mol. Neurobiol. 20, 125-142. doi: 10.1007/bf02742438
17. Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., et al. (1989). A multiubiquitin chain is confined to specific lysine in a targeted short-livedprotein. Science 243, 1576-1583. doi: 10.1126/science.2538923
18. Chen, S., and Brown, I. R. (2007). Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases. Cell Stress Chaperones 12, 51-58. doi: 10.1379/csc-236r.1
19. Chen, J., Huang, R. Y., and Turko, I. V. (2013). Mass spectrometry assessment of ubiquitin carboxyl-terminal hydrolase L1 partitioning between soluble and particulate brain homogenate fractions. Anal. Chem. 85, 6011-6017. doi: 10.1021/ac400831z
20. Chen, F., Sugiura, Y., Myers, K. G., Liu, Y., and Lin, W. (2010). Ubiquitin carboxyl- terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction. Proc. Natl. Acad. Sci. U S A 107, 1636-1641. doi: 10.1073/pnas.0911516107
21. Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L. S., et al. (2004). Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson’s and Alzheimer’s diseases. J. Biol. Chem. 279, 13256-13264. doi: 10.1074/jbc.m314124200
22. Ciechanover, A., and Kwon, Y. T. (2015). Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp. Mol. Med. 47:e147. doi: 10.1038/emm.2014.117
23. Coleman, M. P., and Perry, V. H. (2002). Axon pathologyin neurological disease: a neglected therapeutic target. Trends Neurosci. 25, 532-537. doi: 10.1016/s0166-2236(02)02255-5
24. Cotto-Rios, X. M., Bekes, M., Chapman, J., Ueberheide, B., and Huang, T. T. (2012). Deubiquitinases as a signaling target of oxidative stress. Cell Rep. 2, 1475-1484. doi: 10.1016/j.celrep.2012.11.011
25. Courtine, G., Song, B., Roy, R. R., Zhong, H., Herrmann, J. E., Ao, Y., et al. (2008). Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat. Med. 14, 69-74. doi: 10.1038/nm1682
26. Dasuri, K., Ebenezer, P. J., Zhang, L., Fernandez-Kim, S. O., Uranga, R. M., Gavilan, E., et al. (2010). Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins. FreeRadic. Biol. Med. 49,1290-1297. doi: 10.1016/j.freeradbiomed.2010.07.014
27. Dasuri, K., Zhang, L., and Keller, J. N. (2013). Oxidative stress, neurodegeneration and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 62, 170-185. doi: 10.1016/j.freeradbiomed.2012.09.016
28. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., and Glabe, C. G. (2005). Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280, 17294-17300. doi: 10.1074/jbc.m500997200
29. Dennissen, F. J., Kholod, N., Steinbusch, H. W., and van Leeuwen, F. W. (2010). Misframed proteins and neurodegeneration: a novel view on Alzheimer’s and Parkinson’s diseases. Neurodegener. Dis. 7, 76-79. doi: 10.1159/000285510
30. Ding, Q., Dimayuga, E., and Keller, J. N. (2006). Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid. Redox Signal. 8, 163-172. doi: 10.1089/ars.2006.8.163
31. Du, Y., Li, X., Yang, D., Zhang, X., Chen, S., Huang, K., et al. (2008). Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo. Exp. Biol. Med. (Maywood) 233, 881-890. doi: 10.3181/0712-rm-329
32. Eckert, A., Schmitt, K., and Gotz, J. (2011). Mitochondrial dysfunction - the beginning of the end in Alzheimer’s disease? Separate and synergistic modes oftau and amyloid-p toxicity. AlzheimersRes. Ther. 3:15. doi: 10.1186/alzrt74
33. Ehlers, M. D. (2003). Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6, 231-242. doi: 10.1038/nn1013
34. El Ayadi, A., Stieren, E. S., Barral, J. M., and Boehning, D. (2012). Ubiquilin- 1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688. Proc. Natl. Acad. Sci. USA 109, 13416-13421. doi: 10.1073/pnas.1206786109
35. Eletr, Z. M., and Wilkinson, K. D. (2014). Regulation of proteolysis by human deubiquitinating enzymes. Biochim. Biophys. Acta 1843, 114-128. doi: 10.1016/j.bbamcr.2013.06.027
36. Falsone, S. F., Meyer, N. H., Schrank, E., Leitinger, G., Pham, C. L., Fodero-Tavoletti, M. T., et al. (2012). SERF protein is a direct modifier of amyloid fiber assembly. CellRep. 2, 358-371. doi: 10.1016/j.celrep.2012.06.012
37. Farah, M. H., Pan, B. H., Hoffman, P. N., Ferraris, D., Tsukamoto, T., Nguyen, T., et al. (2011). Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system. J. Neurosci. 31, 5744-5754. doi: 10.1523/JNEUROSCI.6810-10.2011
38. Farhoud, M. H., Nijtmans, L. G., Wanders, R. J., Wessels, H. J., Lasonder, E., Janssen, A. J., et al. (2012). Impaired ubiquitin-proteasome-mediated PGC-1a protein turnover and induced mitochondrial biogenesis secondary to complex- I deficiency. Proteomics 12, 1349-1362. doi: 10.1002/pmic.201100326
39. Ferreira, A., and Bigio, E. H. (2011). Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies. Mol. Med. 17, 676-685. doi: 10.2119/molmed.2010.00220
40. Fioravante, D., and Byrne, J. H. (2011). Protein degradation and memory formation. Brain Res. Bull. 85, 14-20. doi: 10.1016/j.brainresbull.2010.11.002
41. Fry, E. J., Stolp, H. B., Lane, M. A., Dziegielewska, K. M., and Saunders, N. R. (2003). Regeneration of supraspinal axons after complete transection of the thoracic spinal cord in neonatal opossums (Monodelphis domestica). J. Comp. Neurol. 466, 422-444. doi: 10.1002/cne.10904
42. Garcia Gil, M. L., Moran, M. A., and Gomez-Ramos, P. (2001). Ubiquitinated granular structures and initial neurofibrillary changes in the human brain. J. Neurol. Sci. 192, 27-34. doi: 10.1016/s0022-510x(01)00587-1
43. Garg, S., Timm, T., Mandelkow, E. M., Mandelkow, E., and Wang, Y. (2011). Cleavage of Tau by calpain in Alzheimer’s disease: the quest for the toxic 17 kD fragment. Neurobiol. Aging 32, 1-14. doi: 10.1016/j.neurobiolaging.2010.09.008
44. Gentier, R. J., and van Leeuwen, F. W. (2015). Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease. Front. Mol. Neurosci. 8:47. doi: 10.3389/fnmol.2015.00047
45. Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., et al. (2006). Ubiquitin hydrolase Uch-L1 rescues p-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788. doi: 10.1016/j.cell.2006.06.046
46. Gong, B., Chen, F., Pan, Y., Arrieta-Cruz, I., Yoshida, Y., Haroutunian, V., et al. (2010). SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer’s disease amyloidosis and improves synaptic function. Aging Cell 9, 1018-1031. doi: 10.1111/j.1474-9726.2010.00632.x
47. Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., et al. (2013a). Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-y coactivator 1a regulated p-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol. Aging 34, 1581-1588. doi: 10.1016/j.neurobiolaging.2012.12.005
48. Gong, B., Pan, Y., Zhao, W., Knable, L., Vempati, P., Begum, S., et al. (2013b). IVIG immunotherapy protects against synaptic dysfunction in Alzheimer’s disease through complement anaphylatoxin C5a-mediated AMPA-CREB- C/EBP signaling pathway. Mol. Immunol. 56, 619-629. doi: 10.1016/j.molimm.2013.06.016
49. Gong, B., Vitolo, O.V., Trinchese, F., Liu, S., Shelanski, M., and Arancio, O. (2004). Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest. 114, 1624-1634. doi: 10.1172/jci200422831
50. Grune, T., Jung, T., Merker, K., and Davies, K. J. (2004). Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid and ‘aggresomes’ during oxidative stress, aging and disease. Int. J. Biochem. Cell Biol. 36, 2519-2530. doi: 10.1016/j.biocel.2004.04.020
51. Hegde, A. N., Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain, D. G., et al. (1997). Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89, 115-126. doi: 10.1016/s0092-8674(00)80188-9
52. Henninger, N., Sicard, K. M., Bouley, J., Fisher, M., and Stagliano, N. E. (2006). The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia. Neurosci. Lett. 398, 300-305. doi: 10.1016/j.neulet.2006.01.015
53. Hiltunen, M., Lu, A., Thomas, A. V., Romano, D. M., Kim, M., Jones, P. B., et al. (2006). Ubiquilin 1 modulates amyloid precursor protein trafficking and Ap secretion. J. Biol. Chem. 281,32240-32253. doi: 10.1074/jbc.m603106200
54. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., et al. (1995). Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218. doi: 10.1016/0896-6273(95)90107-8
55. Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., et al. (2006). Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525. doi: 10.1038/nn1797
56. Huang, Q., and Figueiredo-Pereira, M. E. (2010). Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15, 1292-1311. doi: 10.1007/s10495-010-0466-z
57. Huang, W. L., George, K. J., Ibba, V., Liu, M. C., Averill, S., Quartu, M., et al. (2007). The characteristics of neuronal injury in a static compression model of spinal cord injury in adult rats. Eur. J. Neurosci. 25, 362-372. doi: 10.1111/j.1460-9568.2006.05284.x
58. Huang, Q., Wang, H., Perry, S. W., and Figueiredo-Pereira, M. E. (2013). Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J. Biol. Chem. 288, 12161-12174. doi: 10.1074/jbc.m113.464552
59. Hunter, T. (2007). The age of crosstalk: phosphorylation, ubiquitination and beyond. Mol. Cell 28,730-738. doi: 10.1016/j.molcel.2007.11.019
60. Irmler, M., Gentier, R. J., Dennissen, F. J., Schulz, H., Bolle, I., Holter, S. M., et al. (2012). Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients. Acta Neuropathol. 124, 187-197. doi: 10.1007/s00401-012-1003-7
61. Jarome, T. J., Kwapis, J. L., Hallengren, J. J., Wilson, S. M., and Helmstetter, F. J. (2013). The ubiquitin-specific protease 14 (USP14) is a critical regulator of long-term memory formation. Learn. Mem. 21, 9-13. doi: 10.1101/lm.032771.113
62. Ji, B., Case, L. C., Liu, K., Shao, Z., Lee, X., Yang, Z., et al. (2008). Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury. Mol. Cell. Neurosci. 39, 258-267. doi: 10.1016/j.mcn.2008.07.004
63. Kaang, B. K., and Choi, J. H. (2012). Synaptic protein degradation in memory reorganization. Adv. Exp. Med. Biol. 970, 221-240. doi: 10.1007/978-3-7091-0932-8_10
64. Kanamaru, Y., Sekine, S., Ichijo, H., and Takeda, K. (2012). The phosphorylation- dependent regulation of mitochondrial proteins in stress responses. J. Signal Transduct. 2012:931215. doi: 10.1155/2012/931215
65. Kaneko, M., Koike, H., Saito, R., Kitamura, Y., Okuma, Y., and Nomura, Y. (2010). Loss ofHRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloid-p generation. J. Neurosci. 30, 3924-3932. doi: 10.1523/JNEUROSCI.2422-09.2010
66. Kang, E. L., Cameron, A. N., Piazza, F., Walker, K. R., and Tesco, G. (2010). Ubiquitin regulates GGA3-mediated degradation ofBACE1. J. Biol. Chem. 285, 24108-24119. doi: 10.1074/jbc.M109.092742
67. Kato, A., Rouach, N., Nicoll, R. A., and Bredt, D. S. (2005). Activity- dependent NMDA receptor degradation mediated by retrotranslocation and ubiquitination. Proc. Natl. Acad. Sci. USA 102, 5600-5605. doi: 10.1073/pnas.0501769102
68. Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., and Popovich, P. G. (2009). Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435-13444. doi: 10.1523/JNEUROSCI.3257-09.2009
69. Kikuchi, S., Shinpo, K., Takeuchi, M., Tsuji, S., Yabe, I., Niino, M., et al. (2002). Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons. J. Neurosci. Res. 69, 373-381. doi: 10.1002/jnr.10298
70. Ko, M. H., and Puglielli, L. (2009). Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels. J. Biol. Chem. 284, 2482-2492. doi: 10.1074/jbc.M804901200
71. Kobayashi, S., Sasaki, T., Katayama, T., Hasegawa, T., Nagano, A., and Sato, K. (2010). Temporal-spatial expression of presenilin 1 and the production of amyloid-p after acute spinal cord injury in adult rat. Neurochem. Int. 56, 387-393. doi: 10.1016/j.neuint.2009.11.005
72. Kumar, P., Ambasta, R. K., Veereshwarayya, V., Rosen, K. M., Kosik, K. S., Band, H., et al. (2007). CHIP and HSPs interact with p-APP in a proteasome- dependent manner and influence Ap metabolism. Hum. Mol. Genet. 16, 848-864. doi: 10.1093/hmg/ddm030
73. Kumar, P., Jha, N. K., Jha, S. K., Ramani, K., and Ambasta, R. K. (2015). Tau phosphorylation, molecular chaperones and ubiquitin E3 ligase: clinical relevance in Alzheimer’s disease. J. Alzheimers Dis. 43, 341-361. doi: 10.3233/JAD-140933
74. Kurihara, L. J., Kikuchi, T., Wada, K., and Tilghman, S. M. (2001). Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia. Hum. Mol. Genet. 10, 1963-1970. doi: 10.1093/hmg/10.18.1963
75. Lane, M. A., Truettner, J. S., Brunschwig, J. P., Gomez, A., Bunge, M. B., Dietrich, W. D., et al. (2007). Age-related differences in the local cellular and molecular responses to injury in developing spinal cord of the opossum, Monodelphis domestica. Eur. J. Neurosci. 25, 1725-1742. doi: 10.1111/j.1460-9568.2007.05439.x
76. Larsen, C. N., Krantz, B. A., and Wilkinson, K. D. (1998). Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37, 3358-3368. doi: 10.1021/bi972274d
77. Laser, H., Mack, T. G., Wagner, D., and Coleman, M. P. (2003). Proteasome inhibition arrests neurite outgrowth and causes ‘‘dying-back’’ degeneration in primaryculture. J. Neurosci. Res. 74, 906-916. doi: 10.1002/jnr.10806
78. Lazarov, O., Morfini, G. A., Pigino, G., Gadadhar, A., Chen, X., Robinson, J., et al. (2007). Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer’s disease-linked mutant presenilin 1. J. Neurosci. 27, 7011-7020. doi: 10.1523/jneurosci.4272-06.2007
79. Lee, L., Kosuri, P., and Arancio, O. (2014). Picomolar amyloid-p peptides enhance spontaneous astrocyte calcium transients. J. Alzheimers Dis. 38, 49-62. doi: 10.3233/JAD-130740
80. Leigh, P. N., Whitwell, H., Garofalo, O., Buller, J., Swash, M., Martin, J. E., et al. (1991). Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Brain 114, 775-788.doi: 10.1093/brain/114.2.775
81. Li, G. L., and Farooque, M. (1996). Expression of ubiquitin-like immunoreactivity in axons after compression trauma to rat spinal cord. Acta Neuropathol. 91, 155-160. doi: 10.1007/s004010050407
82. Li, G. L., Farooque, M., Holtz, A., and Olsson, Y. (1995). Changes of p-amyloid precursor protein after compression trauma to the spinal cord: an experimental study in the rat using immunohistochemistry. J. Neurotrauma 12, 269-277. doi: 10.1089/neu.1995.12.269
83. Li, C., Ma, J., Zhao, H., Blagg, B. S., and Dobrowsky, R. T. (2012). Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun. ASN Neuro 4:e00102. doi: 10.1042/20120047
84. Li, J., Pauley, A. M., Myers, R. L., Shuang, R., Brashler, J. R., Yan, R., et al. (2002). SEL-10 interacts with presenilin 1, facilitates its ubiquitination and alters A-p peptide production. J. Neurochem. 82, 1540-1548. doi: 10.1046/j.1471-4159.2002.01105.x
85. Li, J. M., Xue, Z. Q., Deng, S. H., Luo, X. G., Patrylo, P. R., Rose, G. W., et al. (2013). Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury. Neurotox. Res. 24, 1-14. doi: 10.1007/s12640-012-9355-2
86. Lin, A. W., and Man, H. Y. (2013). Ubiquitination of neurotransmitter receptors and postsynaptic scaffolding proteins. Neural Plast. 2013:432057. doi: 10.1155/2013/432057
87. Lindsten, K., de Vrij, F. M., Verhoef, L. G., Fischer, D. F., van Leeuwen, F. W., Hol, E. M., et al. (2002). Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. CellBiol. 157, 417-427. doi: 10.1083/jcb.200111034
88. Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., and Lansbury, P. T., Jr. (2002). The Uch-L1 gene encodes two opposing enzymatic activities that affect a-synuclein degradation and Parkinson’s disease susceptibility. Cell 111, 209-218. doi: 10.1016/s0092-8674(02)01012-7
89. Liu, C. W., Li, X., Thompson, D., Wooding, K., Chang, T. L., Tang, Z., et al. (2006). ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol. Cell 24,39-50. doi: 10.1016/j.molcel.2006.08.025
90. Liu, Z., Meray, R. K., Grammatopoulos, T. N., Fredenburg, R. A., Cookson, M. R., Liu, Y., et al. (2009). Membrane-associated farnesylated Uch-L1 promotes a- synuclein neurotoxicity and is a therapeutic target for Parkinson’s disease. Proc. Natl. Acad. Sci. USA 106,4635-4640. doi: 10.1073/pnas.0806474106
91. Livnat-Levanon, N., and Glickman, M. H. (2011). Ubiquitin-proteasome system and mitochondria - reciprocity. Biochim. Biophys Acta 1809, 80-87. doi: 10.1016/j.bbagrm.2010.07.005
92. Maharjan, S., Oku, M., Tsuda, M., Hoseki, J., and Sakai, Y. (2014). Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Sci. Rep. 4:5896. doi: 10.1038/srep05896
93. Manczak, M., and Reddy, P. H. (2012). Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer’s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 21, 2538-2547. doi: 10.1093/hmg/dds072
94. Massey, L. K., Mah, A. L., Ford, D. L., Miller, J., Liang, J., Doong, H., et al. (2004). Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J. Alzheimers Dis. 6, 79-92.
95. Medana, I. M., and Esiri, M. M. (2003).Axonal damage: a keypredictor of outcome in human CNS diseases. Brain 126, 515-530. doi: 10.1093/brain/awg061
96. Mengesdorf, T., Jensen, P. H., Mies, G., Aufenberg, C., and Paschen, W. (2002). Down-regulation of parkin protein in transient focal cerebral ischemia: a link between stroke and degenerative disease? Proc. Natl. Acad. Sci. U S A 99, 15042-15047. doi: 10.1073/pnas.232588799
97. Merrill, R. A., Dagda, R. K., Dickey, A. S., Cribbs, J. T., Green, S. H., U S Achev, Y. M., et al. (2011). Mechanism of neuroprotective mitochondrial remodeling byPKA/AKAP1. PLoS Biol. 9:e1000612. doi: 10.1371/journal.pbio.1000612
98. Metcalfe, M. J., Huang, Q., and Figueiredo-Pereira, M. E. (2012). Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis. 3:e326. doi: 10.1038/cddis.2012.70
99. Moore, S. W., and Kennedy, T. E. (2006). Protein kinase A regulates the sensitivity of spinal commissural axon turning to netrin-1 but does not switch between chemoattraction and chemorepulsion. J. Neurosci. 26, 2419-2423. doi: 10.1523/jneurosci.5419-05.2006
100. Mosconi, L., Pupi, A., and De Leon, M. J. (2008). Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease. Ann.NYAcad. Sci. 1147, 180-195. doi: 10.1196/annals.1427.007
101. Myeku, N., Wang, H., and Figueiredo-Pereira, M. E. (2012). camp stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. Neurosci. Lett. 527, 126-131. doi: 10.1016/j.neulet.2012.08.051
102. Nakatsu, F., Sakuma, M., Matsuo, Y., Arase, H., Yamasaki, S., Nakamura, N., et al. (2000). A Di-leucine signal in the ubiquitin moiety. J. Biol. Chem. 275, 26213-26219. doi: 10.1074/jbc.m907720199
103. Nashmi, R., and Fehlings, M. G. (2001). Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassiumchannels. Brain Res. Brain Res. Rev. 38,165-191. doi: 10.1016/s0165-0173(01)00134-5
104. Naujokat, C. (2009). Role of ubiquitin ligases in neural stem and progenitor cells. Arch. Immunol. Ther. Exp. (Warsz) 57, 177-188. doi: 10.1007/s00005-009-0019-8
105. Navakkode, S., Sajikumar, S., and Frey, J. U. (2004). The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long­term potentiation and synaptic tagging. J. Neurosci. 24, 7740-7744. doi: 10.1523/jneurosci.1796-04.2004
106. Nelson, R. F., Glenn, K. A., Miller, V. M., Wen, H., and Paulson, H. L. (2006). A novel route for F-box protein-mediated ubiquitination links CHIP to glycoprotein qualitycontrol. J. Biol. Chem. 281,20242-20251. doi: 10.1074/jbc.m602423200
107. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. doi: 10.1126/science.1134108
108. Nicholls, D. G. (2008). Oxidative stress and energycrises in neuronal dysfunction. Ann.NY Acad. Sci. 1147,53-60.doi: 10.1196/annals.1427.002
109. Noor, N. M., Mollgard, K., Wheaton, B. J., Steer, D. L., Truettner, J. S., Dziegielewska, K. M., et al. (2013). Expression and cellular distribution of ubiquitin in response to injury in the developing spinal cord of Monodelphis domestica. PLoS One 8:e62120. doi: 10.1371/journal.pone.0062120
110. Noor, N. M., Steer, D. L., Wheaton, B. J., Ek, C. J., Truettner, J. S., Dietrich, W. D., et al. (2011). Age-dependent changes in the proteome following complete spinal cord transection in a postnatal South American opossum (Monodelphis domestica). PLoS One 6:e27465. doi: 10.1371/journal.pone.0027465
111. O’Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., et al. (2008). Phosphorylation of the translation initiation factor eIF2a increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 988-1009. doi: 10.1016/j.neuron.2008.10.047
112. Oddo, S. (2008). The ubiquitin-proteasome system in Alzheimer’s disease. J. Cell. Mol. Med. 12, 363-373. doi: 10.1111/j.1582-4934.2008.00276.x
113. Osaka, H., Wang, Y. L., Takada, K., Takizawa, S., Setsuie, R., Li, H., et al. (2003). Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 12, 1945-1958. doi: 10.1093/hmg/ddg211
114. Pajoohesh-Ganji, A., Burns, M. P., Pal-Ghosh, S., Tadvalkar, G., Hokenbury, N. G., Stepp, M. A., et al. (2014). Inhibition of amyloid precursor protein secretases reduces recoveryafterspinalcordinjury. Brain Res. 1560, 73-82. doi: 10.1016/j.brainres.2014.02.049
115. Pajoohesh-Ganji, A., and Byrnes, K. R. (2011). Novel neuroinflammatory targets in the chronically injured spinal cord. Neurotherapeutics 8, 195-205. doi: 10.1007/s13311-011-0036-2
116. Patrick, G. N. (2006). Synapse formation and plasticity: recent insights from the perspective of the ubiquitin proteasome system. Curr. Opin. Neurobiol. 16, 90-94. doi: 10.1016/j.conb.2006.01.007
117. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1993). Neurodegeneration induced by p-amyloid peptides in vitro: the role of peptide assemblystate. J.Neurosci. 13, 1676-1687.
118. Pimplikar, S. W., Nixon, R. A., Robakis, N. K., Shen, J., and Tsai, L. H. (2010). Amyloid-independent mechanisms in Alzheimer’s disease pathogenesis. J. Neurosci. 30, 14946-14954. doi: 10.1523/JNEUROSCI.4305-10.2010
119. Poon, W. W., Carlos, A. J., Aguilar, B. L., Berchtold, N. C., Kawano, C. K., Zograbyan, V., et al. (2013). p-Amyloid (Ap) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, Uch-L1. J. Biol. Chem. 288, 16937-16948. doi: 10.1074/jbc.M113.463711
120. Qing, H., Zhou, W., Christensen, M. A., Sun, X., Tong, Y., and Song, W. (2004). Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J. 18, 1571-1573. doi: 10.1096/fj.04-1994fje
121. Riederer, B. M., Leuba, G., Vernay, A., and Riederer, I. M. (2011). The role of the ubiquitin proteasome system in Alzheimer’s disease. Exp. Biol. Med. (Maywood) 236, 268-276. doi: 10.1258/ebm.2010.010327
122. Rose, P. K., and Odlozinski, M. (1998). Expansion of the dendritic tree of motoneurons innervating neck muscles of the adult cat after permanent axotomy. J. Comp. Neurol. 390, 392-411. doi: 10.1002/(sici)1096- 9861(19980119)390:3<392::aid-cne7>3.0.co;2-x
123. Saito, K., Elce, J. S., Hamos, J. E., and Nixon, R. A. (1993). Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. USA 90,2628-2632. doi: 10.1073/pnas.90.7.2628
124. Sakurai, M., Ayukawa, K., Setsuie, R., Nishikawa, K., Hara, Y., Ohashi, H., et al. (2006). Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J. Cell Sci. 119, 162-171. doi: 10.1242/jcs.02716
125. Sakurai, M., Hayashi, T., Abe, K., Aoki, M., Sadahiro, M., and Tabayashi, K. (1998). Enhancement of heat shock protein expression after transient ischemia in the preconditioned spinal cord of rabbits. J. Vasc. Surg. 27, 720-725. doi: 10.1016/s0741-5214(98)70238-1
126. Schwartz, A. L., and Ciechanover, A. (2009). Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 49,73-96. doi: 10.1146/annurev.pharmtox.051208.165340
127. Selfridge, J. E.EL., Lu, J., and Swerdlow, R. H. (2013). Role of mitochondrial homeostasis and dynamics in Alzheimer’s disease. Neurobiol. Dis. 51, 3-12. doi: 10.1016/j.nbd.2011.12.057
128. Shabek, N., Herman-Bachinsky, Y., and Ciechanover, A. (2009). Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination- independent mode, provides clues to proteasome regulation. Proc. Natl. Acad. Sci. USA 106, 11907-11912. doi: 10.1073/pnas.0905746106
129. Shah, I. M., and Di Napoli, M. (2007). The ubiquitin-proteasome system and proteasome inhibitors in central nervous system diseases. Cardiovasc. Hematol. DisordDrugTargets 7,250-273. doi: 10.2174/187152907782793572
130. Shang, F., and Taylor, A. (2011). Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic. Biol. Med. 51, 5-16. doi: 10.1016/j.freeradbiomed.2011.03.031
131. Sheng, Z. H., and Cai, Q. (2012). Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci. 13, 77-93. doi: 10.1038/nrn3156
132. Sheng, B., Wang, X., Su, B., Lee, H. G., Casadesus, G., Perry, G., et al. (2012). Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. J. Neurochem. 120, 419-429. doi: 10.1111/j.1471-4159.2011.07581.x
133. Shih, S. C., Sloper-Mould, K. E., and Hicke, L. (2000). Monoubiquitin carries a novel internalization signal that is appended to activated receptors. EMBO J. 19, 187-198. doi: 10.1093/emboj/19.2.187
134. Silva, G. M., Finley, D., and Vogel, C. (2015). K63 polyubiquitination is a new modulator of the oxidative stress response. Nat. Struct. Mol. Biol. 22, 116-123. doi: 10.1038/nsmb.2955
135. Singh, A. K., and Pati, U. (2015). CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of p-secretase. AgingCell 14, 595-604. doi: 10.1111/acel.12335
136. Smith, D. L., Pozueta, J., Gong, B., Arancio, O., and Shelanski, M. (2009). Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc. Natl. Acad. Sci. USA 106, 16877-16882. doi: 10.1073/pnas.0908706106
137. Staal, J. A., Dickson, T. C., Chung, R. S., and Vickers, J. C. (2007). Cyclosporin- A treatment attenuates delayed cytoskeletal alterations and secondary axotomy following mild axonal stretch injury. Dev. Neurobiol. 67, 1831-1842. doi: 10.1002/dneu.20552
138. Stadtman, E. R., and Berlett, B. S. (1998). Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev. 30, 225-243. doi: 10.3109/03602539808996310
139. Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., et al. (2008). Amyloid precursor protein-induced axonopathies are independent of amyloid-p peptides. Hum. Mol. Genet. 17, 3474-3486. doi: 10.1093/hmg/ddn240
140. Stranahan, A. M., and Mattson, M. P. (2012). Recruiting adaptive cellular stress responses for successful brain ageing. Nat. Rev. Neurosci. 13, 209-216. doi: 10.1038/nrn3151
141. Tan, Z., Sun, X., Hou, F. S., Oh, H. W., Hilgenberg, L. G., Hol, E. M., et al. (2007). Mutant ubiquitin found in Alzheimer’s disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 14, 1721-1732. doi: 10.1038/sj.cdd.4402180
142. Tang-Schomer, M. D., Patel, A. R., Baas, P. W., and Smith, D. H. (2010). Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly and axon degeneration. FASEB J. 24, 1401-1410. doi: 10.1096/fj.09-142844
143. Taylor, E. B., and Rutter, J. (2011). Mitochondrial quality control by the ubiquitin-proteasome system. Biochem. Soc. Trans. 39, 1509-1513. doi: 10.1042/BST0391509
144. Trausch-Azar, J., Leone, T. C., Kelly, D. P., and Schwartz, A. L. (2010). Ubiquitin proteasome-dependent degradation of the transcriptional coactivator PGC-1a via the N-terminal pathway. J. Biol. Chem. 285, 40192-40200. doi: 10.1074/jbc.M110.131615
145. Upadhya, S. C., and Hegde, A. N. (2007). Role of the ubiquitin proteasome system in Alzheimer’s disease. BMCBiochem. 8(Suppl. 1):S12. doi: 10.1186/1471-2091-8-S1-S12
146. van Ham, T. J., Holmberg, M. A., van der Goot, A. T., Teuling, E., Garcia- Arencibia, M., Kim, H. E., et al. (2010). Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell 142, 601-612. doi: 10.1016/j.cell.2010.07.020
147. van Leeuwen, F. W., de Kleijn, D. P., van den Hurk, H. H., Neubauer, A., Sonnemans, M. A., Sluijs, J. A., et al. (1998). Frameshift mutants of p amyloid precursor protein and ubiquitin-B in Alzheimer’s and Down patients. Science 279,242-247. doi: 10.1126/science.279.5348.242
148. van Leeuwen, F. W., Hol, E. M., and Fischer, D. F. (2006). Frameshift proteins in Alzheimer’s disease and in other conformational disorders: time for the ubiquitin-proteasome system. J. Alzheimers Dis. 9, 319-325.
149. van Tijn, P., de Vrij, F. M., Schuurman, K. G., Dantuma, N. P., Fischer, D. F., van Leeuwen, F. W., et al. (2007). Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease. J. Cell Sci. 120, 1615-1623. doi: 10.1242/jcs.03438
150. van Tijn, P., Hobo, B., Verhage, M. C., Oitzl, M. S., van Leeuwen, F. W., and Fischer, D. F. (2011). Alzheimer-associated mutant ubiquitin impairs spatial reference memory. Physiol. Behav. 102, 193-200. doi: 10.1016/j.physbeh.2010.11.001
151. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., et al. (1999). p-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741. doi: 10.1126/science.286.5440.735
152. Viswanathan, J., Haapasalo, A., Bottcher, C., Miettinen, R., Kurkinen, K. M., Lu, A., et al. (2011). Alzheimer’s disease-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation. Traffic 12, 330-348. doi: 10.1111/j.1600-0854.2010.01149.x
153. Vitolo, O. V., Sant’Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., and Shelanski, M. (2002). Amyloid p-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. USA 99, 13217-13221. doi: 10.1073/pnas.172504199
154. Ward, R. E., Huang, W., Kostusiak, M., Pallier, P. N., Michael-Titus, A. T., and Priestley, J. V. (2014). A characterization of white matter pathology following spinal cord compression injury in the rat. Neuroscience 260, 227-239. doi: 10.1016/j.neuroscience.2013.12.024
155. Wilkinson, K. D., Lee, K. M., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., and Pohl, J. (1989). The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246, 670-673. doi: 10.1126/science.2530630
156. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., et al. (2006). Control of peripheral nerve myelination by the p-secretase BACE1. Science 314, 664-666. doi: 10.1126/science.1132341
157. Xie, Y. Y., Yao, Z. B., and Wu, W. T. (2000). Survival of motor neurons and expression of p-amyloid protein in the aged rat spinal cord. Neuroreport 11, 697-700. doi: 10.1097/00001756-200003200-00009
158. Xue, S., and Jia, J. (2006). Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer’s disease in a Chinese Han population. Brain Res. 1087, 28-32. doi: 10.1016/j.brainres.2006.02.121
159. Yamauchi, T., Sakurai, M., Abe, K., Matsumiya, G., and Sawa, Y. (2007). Impact of the endoplasmic reticulum stress response in spinal cord after transient ischemia. Brain Res. 1169, 24-33. doi: 10.1016/j.brainres.2007.06.093
160. Yamauchi, T., Sakurai, M., Abe, K., Matsumiya, G., and Sawa, Y. (2008). Ubiquitin-mediated stress response in the spinal cord after transient ischemia. Stroke 39, 1883-1889. doi: 10.1161/STROKEAHA.106.455832
161. Yan, R., Han, P., Miao, H., Greengard, P., and Xu, H. (2001). The transmembrane domain of the Alzheimer’s p-secretase (BACE1) determines its late Golgi localization and access to p -amyloid precursor protein (APP) substrate. J. Biol. Chem. 276, 36788-36796. doi: 10.1074/jbc.m104350200
162. Yan, X., Liu, J., Luo, Z., Ding, Q., Mao, X., Yan, M., et al. (2010). Proteomic profiling of proteins in rat spinal cord induced by contusion injury. Neurochem. Int. 56, 971-983. doi: 10.1016/j.neuint.2010.04.007
163. Yang, W., Monroe, J., Zhang, Y., George, D., Bremer, E., and Li, H. (2006). Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Lett. 243, 217-227. doi: 10.1016/j.canlet.2005.11.033
164. Yew, E. H., Cheung, N. S., Choy, M. S., Qi, R. Z., Lee, A. Y., Peng, Z. F., et al. (2005). Proteasome inhibition by lactacystin in primary neuronal cells induces both potentiallyneuroprotective and pro-apoptotic transcriptional responses: a microarrayanalysis. J. Neurochem. 94, 943-956. doi: 10.1111/j.1471-4159.2005.03220.x
165. Yokobori, S., Zhang, Z., Moghieb, A., Mondello, S., Gajavelli, S., Dietrich, W. D., et al. (2015). Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report. World Neurosurg. 83, 867-878. doi: 10.1016/j.wneu.2013.03.012
166. Yoshida, Y., Tokunaga, F., Chiba, T., Iwai, K., Tanaka, K., and Tai, T. (2003). Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains. J. Biol. Chem. 278, 43877-43884. doi: 10.1074/jbc.m304157200
167. Zetterberg, M., Sjolander, A., von Otter, M., Palmer, M. S., Landgren, S., Minthon, L., et al. (2010). Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer’s disease. Mol. Neurodegener. 5:11. doi: 10.1186/1750-1326-5-11
168. Zhai, Q., Wang, J., Kim, A., Liu, Q., Watts, R., Hoopfer, E., et al. (2003). Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39, 217-225. doi: 10.1016/s0896-6273(03)00429-x
169. Zhang, M., Deng, Y., Luo, Y., Zhang, S., Zou, H., Cai, F., et al. (2012). Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. J. Neurochem. 120, 1129-1138. doi: 10.1111/j.1471-4159.2011.07644.x
170. Zhang, C., Khandelwal, P. J., Chakraborty, R., Cuellar, T. L., Sarangi, S., Patel, S. A., et al. (2007). An AICD-based functional screen to identify APP metabolism regulators. Mol. Neurodegener. 2:15. doi: 10.1186/1750-1326-2-15
171. Zhao, Y., Hegde, A. N., and Martin, K. C. (2003). The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening. Curr. Biol. 13, 887-898. doi: 10.1016/s0960-9822(03)00332-4
172. Zhu, X., Perry, G., Smith, M. A., and Wang, X. (2013). Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J. Alzheimers Dis. 33(Suppl. 1), S253-S262. doi: 10.3233/JAD-2012-129005